Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 11, 1998, Pages 1070-1077

  Green, Sherril L ^a   Vulliet, P Richard ^b   Pinter, Martin J ^c   Cork, Linda C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cyclin dependent kinase 5; Motor neuron disease

Indexed keywords

CYCLIN DEPENDENT KINASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031729682     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199811000-00010     Document Type: Article

References (63)

1. Cork LC, Griffin JW, Choy C, Padula CA, Price DL. Pathology of motor neurons in accelerated hereditary canine spinal muscular atrophy. Lab Invest 1982;46:89-99
2. Cork LC, Griffin JW, Munnell JF, Lorenz MD, Adams RJ. Hereditary canine spinal muscular atrophy. J Neuropathol Exp Neurol 1979;38:209-21
3. Blazej RG, Mellersh CS, Cork LC, Ostrander EA. Hereditary canine spinal muscular atrophy is phenotypically similar but molecularly distinct from human spinal muscular atrophy. J Hered 1998 (in press)
4. Mellersh CS, Langston AA, Acland GM, et al. A linkage map of the canine genome. Genomics 1997;46:326-36
5. Pinter MJ, Waldeck RF, Wallace N, Cork LC. Motor unit behavior in canine motor neuron disease. J Neurosci 1995;15:3447-57
6. Carden MJ, Schlaepfer WW, Lee VM. The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. J Biol Chem 1985;260: 9805-17
7. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988;57:593-625
8. Liem RK. Molecular biology of neuronal intermediate filaments. Curr Opin Cell Biol 1993;5:12-16
9. Fliegner KH, Liem RK. Cellular and molecular biology of neuronal intermediate filaments. Int Rev Cytol 1991;131:109-67
10. Geisler N, Kaufmann E, Fischer S, Plessman W, Weber K. Neurofilament architecture combines structural principles of intermediate filaments with carboxy-terminal extensions increasing in size between triplet proteins. EMBO Journal 1983;2:1295-302
11. Hirokawa N, Glicksman MA, Willard MB. Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J Cell Biol 1984;98:1523-36
12. Hirokawa N. Cross-linker system between neurofilaments, microtubules, and membranous organelles in frog axons revealed by the quick-freeze, deep-etching method. J Cell Biol 1982;94:129-42
13. Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan NJ, Price DL. Neurofilament gene expression: A major determinant of axonal caliber. Proc Natl Acad Sci USA 1987;84:3472-76
14. Muma NA, Slunt HH, Hoffman PN. Postnatal increases in neurofilament gene expression correlate with the radial growth of axons. J Neurocytol 1991;20:844-54
15. Hisanaga S, Hirokawa N. Dephosphorylation-induced interactions of neurofilaments with microtubules. J Biol Chem 1990;265: 21852-58
16. Nixon RA, Sihag RK. Neurofilament phosphorylation: A new look at regulation and function. Trends Neurosci 1991;14:501-6
17. Dosemeci A, Pant HC. Association of cyclic-AMP-dependent protein kinase with neurofilaments. Biochem J 1992;282 (Pt 2):477-81
18. Dosemeci A, Floyd CC, Pant HC. Characterization of neurofilament-associated protein kinase activities from bovine spinal cord. Cell Mol Neurobiol 1990;10:369-82
19. Elhanany E, Jaffe H, Link WT, Sheeley DM, Gainer H, Pant HC. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J Neurochem 1994;63:2324-35
20. Floyd CC, Grant P, Gallant PE, Pant HC. Principal neurofilament-associated protein kinase in squid axoplasm is related to casein kinase I. J Biol Chem 1991;266:4987-94
21. Julien JP, Mushynski WE. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J Biol Chem 1983;258:4019-25
22. Link WT, Dosemeci A, Floyd CC, Pant HC. Bovine neurofilament-enriched preparations contain kinase activity similar to casein kinase I-neurofilament phosphorylation by casein kinase I (CKI). Neurosci Lett 1993;151:89-93
23. Sihag RK, Nixon RA. Phosphorylation of the amino-terminal head domain of the middle molecular mass 145-kDa subunit of neurofilaments. Evidence for regulation by second messenger-dependent protein kinases. J Biol Chem 1990;265:4166-71
24. Vallano ML, Buckholz TM, DeLorenzo RJ. Phosphorylation of neurofilament proteins by endogenous calcium/calmodulin-dependent protein kinase. Biochem Biophys Res Commun 1985;130: 957-63
25. Veeranna, Amin ND, Ahn NG, et al. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 1998;18:4008-21
26. (p34cdc2/p58cyclin A) phosphorylates bovine neurofilaments. J Neurochem 1992;58:1365-71
27. Guidato S, Tsai LH, Woodgett J, Miller CC. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J Neurochem 1996;66:1698-706
28. cyclin B kinase. Cell Motil Cytoskeleton 1995;31:283-97
29. Hisanaga S, Ishiguro K, Uchida T. Okumura E, Okano T, Kishimoto T. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. J Biol Chem 1993;268: 15056-60
30. Hisanaga S, Kusubata M, Okumura E, Kishimoto T. Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules. J Biol Chem 1991;266: 21798-803
31. Lee VM, Otvos LJ, Carden MJ, Hollosi M, Dietzschold B, Lazzarini RA. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sci USA 1988;85: 1998-2002
32. Lew J, Winkfein RJ, Paudel HK, Wang JH. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem 1992;267:25922-26
33. Lew J, Beaudette K, Litwin CM, Wang JH. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J Biol Chem 1992;267:13383-90
34. Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related protein kinases. EMBO J 1992;11:2909-17
35. Miyasaka H, Okabe S, Ishiguro K, Uchida T, Hirokawa N. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J Biol Chem 1993;268:22695-702
36. Shetty KT, Link WT, Pant HC. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization. Proc Natl Acad Sci U S A 1993;90:6844-48
37. Sun D, Leung CL, Liem RH. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J Biol Chem 1996;271:14245-51
38. Tsai LH, Takahashi T, Caviness VSJ, Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 1993;119:1029-40
39. Shetty KT, Kaech S, Link WT, et al. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem 1995;64:1988-95
40. Ohshima T, Kozak CA, Nagle JW, Pant HC, Brady RO, Kulkarni AB. Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35. Genomics 1996;35:372-75
41. Tsai LH, Delalle I, Caviness VSJ, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994;371:419-23
42. Ishiguro K, Kobayashi S, Omori A, et al. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett 1994;342:203-8
43. Lew J, Huang QQ, Qi Z, et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994;371:423-26
44. Tang D, Yeung J, Lee KY, et al. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 1995;270:26897-903
45. Qi Z, Tang D, Zhu X, Fujita DJ, Wang JH. Association of neurofilament proteins with neuronal Cdk5 activator. J Biol Chem 1998;273:2329-35
46. Lee KY, Johnston RN. Neurofilaments are part of the high molecular weight complex containing neuronal cdc2-like kinase (nclk). Brain Res 1997;773:197-202
47. Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991;56:91-101
48. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-91
49. Trojanowski JQ, Schmidt ML, Shin RW, Bramblett GT, Rao D, Lee VM. Altered tau and neurofilament proteins in neuro-degenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 1993;3:45-54
50. Cork LC, Troncoso JC, Price DL, Stanley EF, Griffin JW. Canine neuroaxonal dystrophy. J Neuropathol Exp Neurol 1983;42:286-96
51. Cork LC, Troncoso JC, Price DL. Canine inherited ataxia. Ann Neurol 1981;9:492-98
52. Singer HS, Cork LC. Canine GM2 gangliosidosis: Morphological and biochemical analysis. Vet Pathol 1989;26:114-20
53. p58cyclin A. J Biol Chem 1991;266:17430-40
54. Vulliet R, Halloran SM, Braun RK, Smith AJ, Lee G. Proline-directed phosphorylation of human Tau protein. J Biol Chem 1992;267:22570-74
55. Lanius RA, Paddon HB, Mezei M, et al. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J Neurochem 1995;65:927-30
56. Vulliet PR, Hall FL, Mitchell JP, Hardie DG. Identification of a novel proline-directed serine/threonine protein kinase in rat pheochromocytoma. J Biol Chem 1989;264:16292-98
57. Beaudette KN, Lew J, Wang JH. Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain. J Biol Chem 1993;268:20825-30
58. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
59. Ino H, Chiba T. Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res 1996;732:179-85
60. Griffin JW, Hoffman PN, Clark AW, Carroll PT, Price DL. Slow axonal transport of neurofilament proteins: Impairment of beta, beta′-iminodipropionitrile administration. Science 1978;202:633-35
61. Henchcliffe C, Burke RE. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci Lett 1997;230:41-44
62. Zhang Q, Ahuja HS, Zakeri ZF, Wolgemuth DJ. Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev Biol 1997;183:222-33
63. Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, Stuenkel EL. Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J Biol Chem 1998;273: 4957-66